吳 青峰

Medicine and Dentistry

1. Analysis 10%
2. Bleeding 7%
3. Cancer Surgery 13%
4. Catheter 49%
5. Cells 8%
6. Circulating Tumor Cell 8%
7. Cohort Analysis 7%
8. Complication 20%
9. Computer Assisted Tomography 9%
10. Disease 8%
11. Disease Free Survival 17%
12. Endoscope 8%
13. Experience 23%
14. Factor Analysis 5%
15. Hospital 16%
16. Incidence 7%
17. Incision 7%
18. Injection 6%
19. Inpatient 6%
20. Lesion 6%
21. Lobectomy 8%
22. Lung Cancer 34%
23. Lymph Node Metastasis 8%
24. Malignant Neoplasm 6%
25. Mediastinal Tumor 13%
26. Mortality 5%
27. Neoadjuvant Therapy 10%
28. Neoplasm 14%
29. Non Small Cell Lung Cancer 34%
30. Odds Ratio 6%
31. Operation Duration 11%
32. Overall Survival 12%
33. Patient 100%
34. Pneumonectomy 12%
35. Pneumothorax 6%
36. Postoperative Complication 7%
37. Postoperative Pain 9%
38. Prognostic Factor 6%
39. Recurrence Risk 6%
40. Recurrent Disease 6%
41. Relapse 8%
42. Superior Vena Cava 22%
43. Surgeon 8%
44. Surgery 54%
45. Survival 15%
46. Therapeutic Procedure 21%
47. Thorax Surgery 14%
48. Thymectomy 13%
49. Video-Assisted Thoracoscopic Surgery 28%
50. Wedge Resection 6%